Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...

Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...

About Corbus Corbus Pharmaceuticals Holdings, Inc. is an oncology and obesity company with a diversified portfolio and is committed to helping people defeat serious illness by bringing innovative ...

Arrowhead Pharmaceuticals has begun laying the groundwork for its ... ll Get There Soon” campaign reflects its potential ...

More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

Global Markets to 2029" looks at the growing demand for inactive ingredients in medications. The market for Excipients, which enhance drug stability ...

Florida Republican Sen. Marco Rubio wrote to the Food and Drug Administration (FDA) and Department of Homeland Security (DHS) ...

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter ... after an account using its name and logo sent out a Tweet, which read ...

Guggenheim Securities Healthcare Innovation Conference (Boston). MacroGenics' Chief Operating Officer, Eric Risser, will ...